Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Subepicardial haematoma, a rare and potentially lethal complication of CTO-PCI: case of an exceptional recovery after conservative management.

de Vos AM, van der Schaaf RJ.

BMJ Case Rep. 2014 Oct 9;2014. pii: bcr2014204767. doi: 10.1136/bcr-2014-204767.

2.

Aortic root dimension changes during systole and diastole: evaluation with ECG-gated multidetector row computed tomography.

de Heer LM, Budde RP, Mali WP, de Vos AM, van Herwerden LA, Kluin J.

Int J Cardiovasc Imaging. 2011 Dec;27(8):1195-204. doi: 10.1007/s10554-011-9838-x. Epub 2011 Feb 27.

3.

Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose.

Rutten A, Meijs MF, de Vos AM, Seidensticker PR, Prokop M.

Eur Radiol. 2010 Aug;20(8):1917-25. doi: 10.1007/s00330-010-1752-4. Epub 2010 Mar 20.

4.

Does slice thickness affect diagnostic performance of 64-slice CT coronary angiography in stable and unstable angina patients with a positive calcium score?

Meijs MF, de Vries JJ, Rutten A, Budde RP, de Vos AM, Meijboom WB, Cramer MJ, de Feyter PJ, Doevendans PA, Prokop M.

Acta Radiol. 2010 May;51(4):427-30. doi: 10.3109/02841851003649274.

PMID:
20233143
5.

Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study.

Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA, Nieman K, van Werkhoven JM, Pundziute G, Weustink AC, de Vos AM, Pugliese F, Rensing B, Jukema JW, Bax JJ, Prokop M, Doevendans PA, Hunink MG, Krestin GP, de Feyter PJ.

J Am Coll Cardiol. 2008 Dec 16;52(25):2135-44. doi: 10.1016/j.jacc.2008.08.058.

6.

Myocardial adipose tissue in healthy postmenopausal women: no relations with vascular risk.

Roos K, Meijs MF, de Vos AM, Rutten A, Doevendans PA, van der Schouw YT, Prokop M, Bots ML, Vonken EJ.

Eur J Clin Invest. 2008 Oct;38(10):786-7. doi: 10.1111/j.1365-2362.2008.02021.x. No abstract available.

PMID:
18837806
7.

Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography.

Gorter PM, de Vos AM, van der Graaf Y, Stella PR, Doevendans PA, Meijs MF, Prokop M, Visseren FL.

Am J Cardiol. 2008 Aug 15;102(4):380-5. doi: 10.1016/j.amjcard.2008.04.002. Epub 2008 May 24.

PMID:
18678291
8.

Non-invasive cardiac assessment in high risk patients (The GROUND study): rationale, objectives and design of a multi-center randomized controlled clinical trial.

de Vos AM, Rutten A, van de Zaag-Loonen HJ, Bots ML, Dikkers R, Buiskool RA, Mali WP, Lubbers DD, Mosterd A, Prokop M, Rensing BJ, Cramer MJ, van Es HW, Moll FL, van de Pavoordt ED, Doevendans PA, Velthuis BK, Mackaay AJ, Zijlstra F, Oudkerk M.

Trials. 2008 Aug 1;9:49. doi: 10.1186/1745-6215-9-49.

9.

Variability of coronary calcium scores throughout the cardiac cycle: implications for the appropriate use of electrocardiogram-dose modulation with retrospectively gated computed tomography.

Rutten A, Krul SP, Meijs MF, de Vos AM, Cramer MJ, Prokop M.

Invest Radiol. 2008 Mar;43(3):187-94. doi: 10.1097/RLI.0b013e31815cdd56.

PMID:
18301315
10.

Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women.

de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A, Gorter PM, Cramer MJ, Doevendans PA, Rensing BJ, Bartelink ML, Velthuis BK, Mosterd A, Bots ML.

Eur Heart J. 2008 Mar;29(6):777-83. Epub 2007 Dec 20.

PMID:
18156138
11.

Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease.

Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y, Doevendans PA, Prokop M, Visseren FL.

Atherosclerosis. 2008 Apr;197(2):896-903. Epub 2007 Sep 19.

PMID:
17884060
12.

Pilot study of dynamic cine CT angiography for the evaluation of abdominal aortic aneurysms: implications for endograft treatment.

Teutelink A, Rutten A, Muhs BE, Olree M, van Herwaarden JA, de Vos AM, Prokop M, Moll FL, Verhagen HJ.

J Endovasc Ther. 2006 Apr;13(2):139-44.

PMID:
16643067
13.

Images in cardiovascular medicine. Multislice computed tomography evaluation 21 years after heterotopic heart transplantation.

de Vos AM, de Jonge N, Rutten A, Doevendans PA, Prokop M, Cramer MJ.

Circulation. 2006 Jan 31;113(4):e57-8. No abstract available.

PMID:
16449720
14.

Progress in noninvasive coronary artery imaging using multislice CT.

Meijs MF, de Vos AM, Rutten A, Prokop M, Cramer MJ, Doevendans PA.

Neth Heart J. 2005 Sep;13(9):312-314.

15.

Adolescent with occluded left main coronary artery.

Wieman R, Beelen D, van der Zwaan C, Lahpor J, de Vos AM, Doevendans PA.

Neth Heart J. 2005 Jun;13(6):239-241.

16.

Suppressor of fused regulates Gli activity through a dual binding mechanism.

Merchant M, Vajdos FF, Ultsch M, Maun HR, Wendt U, Cannon J, Desmarais W, Lazarus RA, de Vos AM, de Sauvage FJ.

Mol Cell Biol. 2004 Oct;24(19):8627-41.

17.

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, Sliwkowski MX.

Cancer Cell. 2004 Apr;5(4):317-28.

18.

The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1.

Christinger HW, Fuh G, de Vos AM, Wiesmann C.

J Biol Chem. 2004 Mar 12;279(11):10382-8. Epub 2003 Dec 18.

19.

The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity.

Hymowitz SG, Compaan DM, Yan M, Wallweber HJ, Dixit VM, Starovasnik MA, de Vos AM.

Structure. 2003 Dec;11(12):1513-20.

20.

Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.

Vajdos FF, Adams CW, Breece TN, Presta LG, de Vos AM, Sidhu SS.

J Mol Biol. 2002 Jul 5;320(2):415-28.

PMID:
12079396
21.

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF.

Li B, Ogasawara AK, Yang R, Wei W, He GW, Zioncheck TF, Bunting S, de Vos AM, Jin H.

Hypertension. 2002 Jun;39(6):1095-100.

PMID:
12052848
23.

Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor.

Yang S, Xin X, Zlot C, Ingle G, Fuh G, Li B, Moffat B, de Vos AM, Gerritsen ME.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1934-40.

PMID:
11742867
24.

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.

Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA.

EMBO J. 2001 Oct 1;20(19):5332-41.

25.

Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions.

Vajdos FF, Ultsch M, Schaffer ML, Deshayes KD, Liu J, Skelton NJ, de Vos AM.

Biochemistry. 2001 Sep 18;40(37):11022-9.

PMID:
11551198
26.

Nerve growth factor: structure and function.

Wiesmann C, de Vos AM.

Cell Mol Life Sci. 2001 May;58(5-6):748-59. Review.

PMID:
11437236
27.

Mutations of ovine and bovine placental lactogens change, in different ways, the biological activity mediated through homologous and heterologous lactogenic receptors.

Helman D, Herman A, Paly J, Livnah O, Elkins PA, de Vos AM, Djiane J, Gertler A.

J Endocrinol. 2001 Apr;169(1):43-54.

PMID:
11250645
28.

Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors.

Yan M, Wang LC, Hymowitz SG, Schilbach S, Lee J, Goddard A, de Vos AM, Gao WQ, Dixit VM.

Science. 2000 Oct 20;290(5491):523-7.

29.

Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor.

Elkins PA, Christinger HW, Sandowski Y, Sakal E, Gertler A, de Vos AM, Kossiakoff AA.

Nat Struct Biol. 2000 Sep;7(9):808-15.

PMID:
10966654
30.

Ligand-binding sites in Ig-like domains of receptor tyrosine kinases.

Wiesmann C, Muller YA, de Vos AM.

J Mol Med (Berl). 2000;78(5):247-60. Review.

PMID:
10954197
31.

Variations on ligand-receptor complexes.

Wiesmann C, de Vos AM.

Nat Struct Biol. 2000 Jun;7(6):440-2. No abstract available.

PMID:
10881184
32.

Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization.

Li B, Fuh G, Meng G, Xin X, Gerritsen ME, Cunningham B, de Vos AM.

J Biol Chem. 2000 Sep 22;275(38):29823-8.

33.

The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.

Fuh G, Garcia KC, de Vos AM.

J Biol Chem. 2000 Sep 1;275(35):26690-5.

34.

Convergent solutions to binding at a protein-protein interface.

DeLano WL, Ultsch MH, de Vos AM, Wells JA.

Science. 2000 Feb 18;287(5456):1279-83.

35.

A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL.

Hymowitz SG, O'Connell MP, Ultsch MH, Hurst A, Totpal K, Ashkenazi A, de Vos AM, Kelley RF.

Biochemistry. 2000 Feb 1;39(4):633-40.

PMID:
10651627
36.

Putting two and two together: crystal structure of the FGF-receptor complex.

Wiesmann C, de Vos AM.

Structure. 1999 Nov 15;7(11):R251-5. Review.

37.

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A, de Vos AM.

Mol Cell. 1999 Oct;4(4):563-71.

38.

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.

Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.

J Mol Biol. 1999 Nov 5;293(4):865-81.

PMID:
10543973
39.

Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.

Starovasnik MA, Christinger HW, Wiesmann C, Champe MA, de Vos AM, Skelton NJ.

J Mol Biol. 1999 Oct 29;293(3):531-44.

PMID:
10543948
40.

Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.

Wiesmann C, Ultsch MH, Bass SH, de Vos AM.

Nature. 1999 Sep 9;401(6749):184-8.

PMID:
10490030
41.

Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.

Ultsch MH, Wiesmann C, Simmons LC, Henrich J, Yang M, Reilly D, Bass SH, de Vos AM.

J Mol Biol. 1999 Jul 2;290(1):149-59.

PMID:
10388563
42.

Crystallization of ovine placental lactogen in a 1:2 complex with the extracellular domain of the rat prolactin receptor.

Christinger HW, Elkins PA, Sandowski Y, Sakal E, Gertler A, Kossiakoff AA, de Vos AM.

Acta Crystallogr D Biol Crystallogr. 1998 Nov 1;54(Pt 6 Pt 2):1408-11.

PMID:
10089521
43.

Crystal structure of the complex between VEGF and a receptor-blocking peptide.

Wiesmann C, Christinger HW, Cochran AG, Cunningham BC, Fairbrother WJ, Keenan CJ, Meng G, de Vos AM.

Biochemistry. 1998 Dec 22;37(51):17765-72.

PMID:
9922142
44.

Structural basis for cytokine hormone-receptor recognition and receptor activation.

Kossiakoff AA, De Vos AM.

Adv Protein Chem. 1998;52:67-108. Review. No abstract available.

PMID:
9917918
45.

Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.

Ultsch M, Lokker NA, Godowski PJ, de Vos AM.

Structure. 1998 Nov 15;6(11):1383-93.

46.

VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.

Muller YA, Chen Y, Christinger HW, Li B, Cunningham BC, Lowman HB, de Vos AM.

Structure. 1998 Sep 15;6(9):1153-67.

48.

Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity.

Clackson T, Ultsch MH, Wells JA, de Vos AM.

J Mol Biol. 1998 Apr 17;277(5):1111-28.

PMID:
9571026
49.
50.

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM.

Cell. 1997 Nov 28;91(5):695-704.

Supplemental Content

Loading ...
Support Center